Clinical Outcomes in Overweight Heart Transplant Recipients
Overview
Affiliations
Background: Few studies have examined the impact of patient weight on heart transplant (HT) outcomes.
Objectives: Nine outcomes were compared in 2 groups of HT recipients (N = 347) based on their mean body mass index (BMI) during the first 3 years post-HT.
Methods: Group 1 consisted of 108 non-overweight patients (BMI <25; mean age 52; 29.6% females; 16.7% minorities). Group 2 consisted of 239 overweight patients (BMI ≥25; mean age 52; 15.9% females; 13.8% minorities). Outcomes were: survival, re-hospitalization, rejections, infections, cardiac allograft vasculopathy (CAV), stroke, renal dysfunction, diabetes, and lymphoma.
Results: Non-overweight patients had shorter survival, were re-hospitalized more days after the HT discharge, and had more lymphoma and severe renal dysfunction. Overweight patients had more CAV, steroid-induced diabetes, and acute rejections.
Conclusions: Overweight HT patients had better survival, but more rejections, CAV, and diabetes. Non-overweight HT patients had worse survival, plus more re-hospitalization time, lymphoma, and renal dysfunction.
Zhong Y, Zhang C, Wang Y, Liu M, Shang X, Dong N Clin Cardiol. 2024; 47(9):e70010.
PMID: 39233528 PMC: 11375284. DOI: 10.1002/clc.70010.
Donald E, Driggin E, Choe J, Batra J, Vargas F, Lindekens J Clin Transplant. 2024; 38(7):e15401.
PMID: 39023081 PMC: 11634378. DOI: 10.1111/ctr.15401.
Implications of obesity across the heart failure continuum.
Elagizi A, Carbone S, Lavie C, Mehra M, Ventura H Prog Cardiovasc Dis. 2020; 63(5):561-569.
PMID: 33002458 PMC: 7521376. DOI: 10.1016/j.pcad.2020.09.005.
Challapalli J, Maynes E, OMalley T, Cross D, Weber M, Choi J Obes Surg. 2020; 30(11):4437-4445.
PMID: 32654017 DOI: 10.1007/s11695-020-04834-4.
Chen A, Ramirez F, Rosenthal D, Couch S, Berry S, Stauffer K J Am Heart Assoc. 2020; 9(3):e013816.
PMID: 31973598 PMC: 7033874. DOI: 10.1161/JAHA.119.013816.